Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Drug
Medications & Supplements/Prescription Drugs

Potassium Chloride Extended Release Capsules Recalled for Dissolution Issues

Agency Publication Date: July 18, 2024
Share:
Sign in to monitor this recall

Summary

RemedyRepack Inc. is recalling 142 blister cards of Potassium Chloride Micro 10mEq K (750 mg) Extended Release Capsules because they failed dissolution tests. This means the medication, originally manufactured by Glenmark and repackaged by RemedyRepack, may not release into the patient's system at the intended rate. The recall affects 30-count blister cards with expiration dates in early 2025.

Risk

If the capsules do not dissolve correctly, the medication may be released too quickly or too slowly. This can lead to irregular potassium levels in the blood, which may cause heart rhythm problems or other serious medical complications.

What You Should Do

  1. This recall affects Potassium Chloride Micro 10mEq K (750 mg) Extended Release Capsules (NDC 70518-1203-03) repackaged by RemedyRepack Inc. and sold in 30-count blister cards.
  2. Check your medication label for lot numbers J0758674-021824 (Expiration 03/31/2025) or J0751898-011424 (Expiration 01/31/2025).
  3. If you have health concerns or are unsure if your medication is affected, contact your healthcare provider or pharmacist immediately.
  4. Return any unused product to the place of purchase for a refund, throw it away, or contact RemedyRepack Inc. for further instructions.
  5. Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional information regarding this recall.

Your Remedy Options

You have 2 options:

๐Ÿ’ฐOption 1: Full Refund
How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund
๐Ÿ—‘๏ธOption 2: Dispose of Product
How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Potassium Chloride Micro 10mEq K (750 mg) Extended Release Capsules (30-count)by Glenmark
Variants: 10mEq K (750 mg), Extended Release, Capsules
Lot Numbers:
J0758674-021824 (Exp 03/31/2025)
J0751898-011424 (Exp 01/31/2025)
NDC:
70518-1203-03

Manufactured by Glenmark, Mahwah, NJ 07430; Repackaged by RemedyRepack Inc., Indiana, PA 15701

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 94888
Status: Resolved
Manufacturer: RemedyRepack Inc.
Sold By: Pharmacies
Manufactured In: United States
Units Affected: 142 blister cards, 30 per blister card
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.